Lindbrook Capital, LLC Red Hill Biopharma Ltd. Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$4.55 - $10.36 $40 - $93	-9 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$5.98 - $7.51 $1,094 - $1,374	-183 Reduced 95.31%	9 $0
Q1 2021 Apr 28, 2021	SELL	$6.98 - $11.29 $307 - $496	-44 Reduced 18.64%	192 $1,000
Q4 2020 Jan 27, 2021	BUY	$7.81 - $10.39 $890 - $1,184	114 Added 93.44%	236 $2,000
Q3 2020 Nov 03, 2020	BUY	$6.34 - $10.83 $773 - $1,321	122 New	122 $1,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $364M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.